LAMBERTUCCI, Catia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.496
EU - Europa 6.470
AS - Asia 4.386
SA - Sud America 656
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 10
Totale 24.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.081
CN - Cina 1.944
RU - Federazione Russa 1.533
PL - Polonia 1.301
SG - Singapore 1.256
IT - Italia 1.046
DE - Germania 638
BR - Brasile 567
GB - Regno Unito 427
UA - Ucraina 394
HK - Hong Kong 368
CA - Canada 362
SE - Svezia 346
FR - Francia 251
FI - Finlandia 212
KR - Corea 181
VN - Vietnam 172
TR - Turchia 146
IE - Irlanda 91
IN - India 70
JP - Giappone 68
MX - Messico 40
NL - Olanda 39
AR - Argentina 35
BE - Belgio 35
ZA - Sudafrica 34
EU - Europa 33
BD - Bangladesh 26
CZ - Repubblica Ceca 25
ES - Italia 25
AT - Austria 24
IR - Iran 19
EC - Ecuador 17
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
ID - Indonesia 13
KE - Kenya 12
LT - Lituania 12
RO - Romania 12
IL - Israele 11
IQ - Iraq 11
TW - Taiwan 10
CH - Svizzera 9
CO - Colombia 9
DZ - Algeria 8
MA - Marocco 8
RS - Serbia 8
SA - Arabia Saudita 8
AU - Australia 7
AZ - Azerbaigian 7
JO - Giordania 7
PE - Perù 7
PK - Pakistan 7
CL - Cile 6
PY - Paraguay 6
VE - Venezuela 6
AM - Armenia 5
BG - Bulgaria 5
DK - Danimarca 5
EG - Egitto 5
TN - Tunisia 5
AL - Albania 4
GR - Grecia 4
LB - Libano 4
PH - Filippine 4
CI - Costa d'Avorio 3
EE - Estonia 3
HR - Croazia 3
KH - Cambogia 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
CM - Camerun 2
GE - Georgia 2
HU - Ungheria 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
Totale 24.120
Salva come PNG Salva come JPEG
Città #
Fairfield 1.293
Warsaw 1.133
Woodbridge 1.112
Ashburn 998
Jacksonville 961
Chandler 762
Houston 697
Seattle 576
Singapore 530
Wilmington 518
Ann Arbor 481
Cambridge 440
Boardman 414
Hong Kong 353
Nanjing 316
Beijing 309
Dallas 244
Toronto 239
Camerino 220
Los Angeles 182
The Dalles 172
Seoul 155
Kraków 152
San Mateo 143
New York 142
Columbus 141
Tongling 140
Dearborn 137
Lawrence 133
Princeton 133
Istanbul 121
Düsseldorf 108
Ogden 108
Moscow 105
Nanchang 102
London 91
Dublin 90
Buffalo 87
Helsinki 84
Lachine 83
Shanghai 81
Chicago 66
Shenyang 65
São Paulo 65
San Diego 63
Kunming 62
Munich 59
Milan 57
Tianjin 56
Council Bluffs 55
Guangzhou 54
Tokyo 54
Ho Chi Minh City 52
Jiaxing 43
Hebei 42
Hanoi 39
Centro 38
Santa Clara 37
Brussels 35
Rome 34
Frankfurt am Main 33
Ningbo 30
Changsha 28
Jinan 28
Orem 28
Atlanta 27
Denver 27
Stockholm 27
Hangzhou 25
Phoenix 25
Verona 24
Wuhan 24
Brooklyn 23
Chennai 23
Dong Ket 23
Poplar 23
Hefei 22
Johannesburg 22
Montreal 22
Norwalk 22
San Francisco 22
Boston 20
Falls Church 20
Orange 20
Turku 20
Bremen 19
Jinhua 19
Philadelphia 19
Redwood City 19
Salt Lake City 19
Mexico City 18
Tampa 18
Zhengzhou 18
Brno 17
Rio de Janeiro 17
Venezia 17
Manchester 16
Belo Horizonte 14
Brasília 14
Nuremberg 14
Totale 16.128
Salva come PNG Salva come JPEG
Nome #
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 405
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 383
Overview on Radiolabel-Free in Vitro Assays for GPCRs 379
Pharmacological characterization of the GPR17 receptor dual profile 355
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 340
The G Protein-Coupled Receptor GPR17: Overview and Update 325
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 325
GPR17 receptor modulators and their therapeutic implications: review of recent patents 278
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 272
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 271
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 262
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 252
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 252
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 249
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 248
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 237
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 233
Biomarkers Mapping in a Neuropathic Pain Mice Model with Sciatic Nerve Chronic Constriction Injury (CCI). 230
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 230
A taxane epoxide from taxus wallichiana 229
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 229
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 226
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 224
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 224
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model 223
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 222
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 221
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 220
Human cytidine deaminase: understanding the catalytic mechanism 220
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 217
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 214
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 212
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 212
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 212
Adenosine deaminase: Functional implications and different classes of inhibitors 210
New sensible method to quantize the intestinal absorption of receptor ligands 210
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 207
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 206
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 202
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 201
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 200
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 199
Antiviral properties of deazaadenine nucleoside derivatives 199
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 198
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 198
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 195
Synthesis of a conformationally restricted analogue of paclitaxel 194
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 194
Synthesis and NMR-Driven Conformational Analysis of Taxol Analogues Conformationally Constrained on the C13 Side Chain 192
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 191
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 189
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 189
Adenosine receptor modeling: what does the A2A crystal structure tell us? 188
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 187
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 187
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases 186
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 185
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 184
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 181
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 180
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 180
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 179
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 179
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor 178
Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5 '-carboxamidoadenosine analogues 178
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 177
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 177
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 176
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 175
The Chemistry and Occurrence of Taxane Derivatives. XXVI. A Reactivity Study on 11(15→1)Abeotaxanes 173
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 171
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 170
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 169
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 168
Coupling of 2,6-disubstituted purines to ribose-modified sugars 166
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 166
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 164
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 164
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 163
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 163
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 162
Effects of 5 '-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors 162
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 161
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities. 157
N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands 155
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists 154
Probing ambiguous base-pairs by genetic transformation with XNA templates 150
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 145
Adenosine receptor agonists:synthesis and binding affinity of 2-(aryl)alkylthioadenosine derivatives 143
Purinergic P2X receptors: Structural models and analysis of receptor-ligand interaction 143
Synthesis of new nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 142
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases 142
Highlights on the development of A(2A) adenosine receptor agonists and antagonists 140
A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders 140
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 140
N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A(3) adenosine receptor 139
Synthesis and biological activity of trisubstituted adenines as A(2A) adenosine receptor antagonists 137
Substituted adenine derivatives as novel P2X3 receptor ligands 135
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 132
Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infectious models 130
Totale 20.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.535
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.203 0 0 0 0 0 376 628 71 278 155 439 256
2021/20221.648 185 417 34 40 77 81 94 127 125 176 114 178
2022/20231.815 203 122 46 308 177 259 9 106 316 105 111 53
2023/20241.412 190 79 95 63 66 127 55 91 163 38 42 403
2024/20254.798 191 112 389 227 181 291 574 1.190 391 295 307 650
2025/20263.538 426 374 693 956 775 314 0 0 0 0 0 0
Totale 24.526